A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of standard dose regimens of rifampicin in patients with pulmonary tuberculosis in Pakistan

By Shaheen Abida   Najmi Muzammil Hasan   Saeed Waseem   Farooqi Zia-Ur-Rehman  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 6, 2012-06 ,pp. : 459-464

Informa Healthcare

Access to resources Recommend Favorite

A Multiple‐Ascending‐Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK‐875, in Subjects With Type 2 Diabetes

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 29-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term effects of inhaled bronchodilators in stable chronic obstructive pulmonary disease

By Antoniu Sabina A  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 431-441

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment

By Moton Allen   Krishna Gopal   Ma Lei   O’Mara Edward   Prasad Pratapa   McLeod James   Preston Richard A.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite